ENABLING INNOVATION IN A REGULATED PHARMA LANDSCAPE

As pharma accelerates investment in AI and personalized engagement, the challenge is no longer understanding potential but applying innovations saleably. Explore how Canadian regulatory frameworks are evolving to prepare for real-world commercial application across AI, real-world evidence, and next-generation engagement models. Take away key insights to:

• Move beyond AI theory to understand how automated and assistant content review is being applied to real-world reviews of promotional and commercial material. Hear what PAAB has learned through developing and growing AI integration in a complex environment.
• Address the tension between speed and rigor by navigating integration of preclearance requirements for AI-driven commercial models
• Identify evolving grey areas in data use and personalized engagement to minimize regulatory risk while maximizing the impact of technology
• Foster industry-regulator collaboration to build transparent frameworks that enable rapid innovation while maintaining the integrity of the PAAB Code